Global /Belgium /Healthcare /Medical Devices /NYXH

Nyxoah S.A.

NYXH

• EBR: NYXH • Delayed

2.50EUR -3.3%

2.89 USD

As of 11 June 2026, Nyxoah S.A. has a market cap of $130.35M USD, ranking #23737 globally and #82 in Belgium. It ranks #2133 in the Healthcare sector, and #442 in the Medical Devices industry.

Global Rank

23737

Country Rank

Sector Rank

2133

Industry Rank

442

Key Stats

Market Cap

$130.35MUSD

112.87M EUR

Enterprise Value

$123.52MUSD

106.94M EUR

Revenue (TTM)

$11.57MUSD

10.02M EUR

EBITDA (TTM)

-$95.12MUSD

-82.35M EUR

Net Income (TTM)

-$104.03MUSD

-90.09M EUR

PS Ratio

11.3

PB Ratio

2.3

Company Profile

Country (HQ)

Belgium

Sector

Healthcare

Industry

Medical Devices

CEO

Olivier Taelman open_in_new

Employees

183

Founded

2009

Website

nyxoah.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.3%	-7.7%	6.4%	-36%	-44%	-37%	-52%	-64%	-86%

News

Markets

Exchange	Ticker	Price	Quotes
Euronext Brussels (EBR) MIC: XBRU PRIMARY	NYXH Nyxoah SA Ordinary Shares ISIN: BE0974358906 Shares Out.: Shares Outstanding: 99.926M¹ Shares Float: 55.251M² TV: TradingView: EURONEXT: NYXH SA: Stock Analysis: EBR: NYXH YF: Yahoo Finance: NYXH.BR GF: Google Finance: EBR: NYXH BA: Barron's: NYXH MS: Morningstar: XBRU: NYXH	2.50 EUR	TV: TradingView: EURONEXT: NYXH SA: Stock Analysis: EBR: NYXH YF: Yahoo Finance: NYXH.BR GF: Google Finance: EBR: NYXH BA: Barron's: NYXH MS: Morningstar: XBRU: NYXH
NASDAQ MIC: XNAS	NYXH Nyxoah SA Ordinary Shares ISIN: BE0974358906 TV: TradingView: NASDAQ: NYXH SA: Stock Analysis: NASDAQ: NYXH YF: Yahoo Finance: NYXH GF: Google Finance: NASDAQ: NYXH NQ: NASDAQ: NYXH BA: Barron's: NYXH MS: Morningstar: XNAS: NYXH	2.93 USD	TV: TradingView: NASDAQ: NYXH SA: Stock Analysis: NASDAQ: NYXH YF: Yahoo Finance: NYXH GF: Google Finance: NASDAQ: NYXH NQ: NASDAQ: NYXH BA: Barron's: NYXH MS: Morningstar: XNAS: NYXH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Nyxoah S.A.

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Similar Companies

Industry: Medical Devices (Belgium)

Name	Market Cap (USD) diff.	PE	Country
Ion Beam Applications S.A. EBR: IBAB	$456.78M 395.53M EUR 250%	31.5	Belgium
Sequana Medical N.V. EBR: SEQUA	$50.3M 43.56M EUR -61%	-	Belgium
MDxHealth S.A. NASDAQ: MDXH	$28.2M -78%	-	Belgium

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 133K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 123K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 122K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 97K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 92K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 78K%	22.2	Ireland

chevron_leftBack